DArecca James
- SEC CIK
- 0001583903
No open-market purchases or sales filed in the past year.
Current role at each company
- PBH Prestige Consumer Healthcare Inc.Directoras of Aug 5, 2026
- HAE Haemonetics CorpEVP, Chief Financial Officeras of May 19, 2026
- TXMD TherapeuticsMD, Inc.Chief Financial Officeras of Aug 12, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists DArecca James as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TXMD TherapeuticsMD, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2021 (view filing) | Aug 12 | Same day | DArecca JamesChief Financial Officer | SSale | −93.3K | $0.87 | −$81.2K | −43.0%123.8K after |